Cardiovascular trials
Trials open to recruitment
BOAT
Bronchiectasis: Optimising Azithromycin prevention Treatment to reduce exacerbations (BOAT): A double-blind pragmatic 2 arm phase IV randomised controlled trial…
EASE-COPD
QUESTION: Can licenced drugs be repurposed to improve recovery from a COPD exacerbation, improve disease stability and avoid the sequelae of recurrent exacerbations heightened cardiovascular risk and mortality?
…
OPACE
Prophylactic azithromycin is recommended as a treatment to reduce the risk of COPD exacerbations on people with COPD at high risk of exacerbations. In clinical practice, there is much uncertainty in how to optimally use this valuable antibiotic…
POPPY
The Preconception to pOst-partum study of cardiometabolic health in Primigravid PregnancY Study (POPPY) is an observational, prospective study, consisting of two arms: a Pregnancy arm (nulliparous women planning their first…
